Evidence map›Paper›PMID 42818483›Full record

ArticleResearch square2026

Visualizing structural dynamics during nuclease activation across evolutionarily diverse IscB and CRISPR-Cas9 enzymes.

Osamu Nureki, Kosuke Onishi, Yutaro Shuto, Josh Müller, Mikihiro Shibata, Satoshi Omura

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Osamu NurekiUniversity of Tokyo.ORCID 0000-0003-1813-7008
Kosuke OnishiUniversity of Tokyo.
Yutaro ShutoThe University of Tokyo.ORCID 0009-0007-8710-4134
Josh MüllerFaculty of Medicine, University of Bern.ORCID 0009-0002-6882-5626
Mikihiro ShibataKanazawa University.ORCID 0000-0001-5041-3979
Satoshi OmuraUniversity of Tokyo.ORCID 0000-0003-2436-0847

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Cas9 nucleases of CRISPR-Cas adaptive immune systems are programmable RNA-guided DNA endonucleases that evolved from the transposon-associated IscB enzymes. Comparative structural studies have revealed substantial architectural elaboration during this evolutionary transition, including the replacement of the larger ωRNA scaffold of IscB with the REC domains of Cas9, capable of recognizing longer guide-target heteroduplexes. However, these evolutionary insights remain restricted to static structural features, and the dynamic properties that underlie nuclease activation have not been systematically explored across the IscB-to-Cas9 lineage. Here, by combining cryo-electron microscopy structural analysis with real-space, real-time high-speed atomic force microscopy imaging, we visualize the stepwise nuclease activation mechanisms of evolutionarily diverse IscB and Cas9 nucleases, including IscB.m13, type II-B PsCas9, type II-C CjCas9, and type II-D Cas9d MG34-1. We show here that the IscB family employs two distinct strategies for HNH autoinhibition, with one representing the direct evolutionary precursor of the Cas9 nuclease activation mechanism. Moreover, although the stacking-based protein-DNA interaction that stabilizes an intermediate state along the activation pathway is conserved in both IscB and Cas9 enzymes, Cas9 has acquired an additional gating element that prevents premature HNH activation immediately before catalysis. Together with previously reported structures of OgeuIscB and SpCas9, these analyses establish an atlas of the structural dynamics underlying nuclease activation across the IscB-to-Cas9 lineage, uncovering both conserved and diversified activation mechanisms and substantially advancing the mechanistic and evolutionary understanding of these RNA-guided endonucleases.

Identifiers

PMID42818483
PMCPMC13622844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.